MedPath

Endothelial Cell Gene Networks of CVD

Withdrawn
Conditions
Coronary Heart Disease
Interventions
Other: isolation of endothelial cells precursors in blood
Registration Number
NCT03529916
Lead Sponsor
Tufts University
Brief Summary

The objective of this study is to identify relevant signature gene networks of cardiovascular disease in endothelial cells derived from circulating endothelial progenitor cells of individuals with established cardiovascular disease (CVD).

Detailed Description

The investigators propose to enroll CVD and healthy subjects between 30 and 60 years of age, matched for age, gender, body mass index, and medication (statin and anti-hypertensive) use. Circulating endothelial progenitor cells will be isolated from blood and cultured in vitro to differentiate into endothelial cells.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
CVD subjectsisolation of endothelial cells precursors in bloodCVD will be defined as \>50% stenosis of one or more coronary arteries as assessed by coronary angiography.
healthy controlsisolation of endothelial cells precursors in bloodhealthy controls defined as not having stenosis of coronary arteries as assessed by coronary angiography.
Primary Outcome Measures
NameTimeMethod
Gene expression10 weeks

Gene expression \[ identify relevant signature gene networks of cardiovascular disease in endothelial cells\]

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Tufts Medical Center - Cardiovascular Clinic

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath